BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24554201)

  • 1. Pilocytic astrocytoma: a review of genetic and molecular factors, diagnostic and prognostic markers.
    Bikowska-Opalach B; Szlufik S; Grajkowska W; Jozwiak J
    Histol Histopathol; 2014 Oct; 29(10):1235-48. PubMed ID: 24554201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targets in pilocytic astrocytoma based on genetic analysis.
    Reis GF; Tihan T
    Semin Pediatr Neurol; 2015 Mar; 22(1):23-7. PubMed ID: 25976257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.
    Yu J; Deshmukh H; Gutmann RJ; Emnett RJ; Rodriguez FJ; Watson MA; Nagarajan R; Gutmann DH
    Neurology; 2009 Nov; 73(19):1526-31. PubMed ID: 19794125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional profiles of pilocytic astrocytoma are related to their three different locations, but not to radiological tumor features.
    Zakrzewski K; Jarząb M; Pfeifer A; Oczko-Wojciechowska M; Jarząb B; Liberski PP; Zakrzewska M
    BMC Cancer; 2015 Oct; 15():778. PubMed ID: 26497896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biomarkers in pediatric glial tumors: a needed wind of change.
    Fontebasso AM; Bechet D; Jabado N
    Curr Opin Oncol; 2013 Nov; 25(6):665-73. PubMed ID: 24097106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.
    Rodriguez FJ; Giannini C; Asmann YW; Sharma MK; Perry A; Tibbetts KM; Jenkins RB; Scheithauer BW; Anant S; Jenkins S; Eberhart CG; Sarkaria JN; Gutmann DH
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1194-204. PubMed ID: 19018242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved grading of IDH-mutated astrocytic gliomas.
    Pirozzi CJ; Yan H
    Nat Rev Neurol; 2018 Jul; 14(7):383-384. PubMed ID: 29855600
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma.
    Sharma MK; Watson MA; Lyman M; Perry A; Aldape KD; Deák F; Gutmann DH
    Neurology; 2006 Jan; 66(1):127-30. PubMed ID: 16401863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilocytic astrocytoma: pathology, molecular mechanisms and markers.
    Collins VP; Jones DT; Giannini C
    Acta Neuropathol; 2015 Jun; 129(6):775-88. PubMed ID: 25792358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age.
    Fontebasso AM; Shirinian M; Khuong-Quang DA; Bechet D; Gayden T; Kool M; De Jay N; Jacob K; Gerges N; Hutter B; Şeker-Cin H; Witt H; Montpetit A; Brunet S; Lepage P; Bourret G; Klekner A; Bognár L; Hauser P; Garami M; Farmer JP; Montes JL; Atkinson J; Lambert S; Kwan T; Korshunov A; Tabori U; Collins VP; Albrecht S; Faury D; Pfister SM; Paulus W; Hasselblatt M; Jones DT; Jabado N
    Oncotarget; 2015 Oct; 6(31):31844-56. PubMed ID: 26378811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
    Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
    Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.
    Sadighi Z; Slopis J
    J Child Neurol; 2013 May; 28(5):625-32. PubMed ID: 23439714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilocytic astrocytoma: correlation between the initial imaging features and clinical aggressiveness.
    Strong JA; Hatten HP; Brown MT; Debatin JF; Friedman HS; Oakes WJ; Tien R
    AJR Am J Roentgenol; 1993 Aug; 161(2):369-72. PubMed ID: 8333380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnostics in central nervous system tumors.
    Fuller CE; Perry A
    Adv Anat Pathol; 2005 Jul; 12(4):180-94. PubMed ID: 16096380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular and cell biology of pediatric low-grade gliomas.
    Chen YH; Gutmann DH
    Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
    Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM
    Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
    Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
    J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
    Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
    Jeuken JW; Wesseling P
    J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior.
    Bannykh SI; Mirocha J; Nuno M; Lopategui J; Kandala G
    Clin Neuropathol; 2014; 33(6):388-98. PubMed ID: 25066317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.